(Rac) -ErSO-DFP
(Rac) -ErSO-DFP is a derivative of ErSO-DFP and a selective small molecule Erα biomodulator. (Rac) -ErSO-DFP againsts ERα+ breast cancer (including resistant tumors) by hyperactiving the Erα-dependent a-UPR (extracted from patent WO2022087234A1) [1].
Product Specifications
CAS Number
[2768139-73-5]
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rac-erso-dfp.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(C=CC=C2C1(N3CCC(F)(CC3)F)C4=CC=C(C=C4)O)C(F)(F)F
Molecular Formula
C20H17F5N2O2
Molecular Weight
412.35
References & Citations
[1]Hergenrother, et al. Enzyme-activating compounds and compositions. Patent WO2022087234A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A4935-10 25 mg
(2R,6R,8S,12S) -1-Aza-10-oxo-12-phenyltricyclo[6.4.01,8.02,6]dodecan-9-one
Ask
View Details